Xinye Xu1, Zijian Li, Wei Gao. 1. Department of Cardiology, Peking University Third Hospital and Key Laboratory of Cardiovascular Molecular Biology and Regulatory peptides, Ministry of Health (Peking University Third Hospital), Beijing , P.R. China.
Abstract
CONTEXT: Growth differentiation factor 15 (GDF-15) is a novel cytokine showing close association with cardiovascular diseases. The biological mechanism and clinical use of GDF-15 in cardiovascular diseases have been well demonstrated. We review recent investigations from both basic research and clinical trials into the biological role of GDF-15. METHODS: The data were obtained mainly from MedLine via PubMed and from our own investigations. RESULTS: Laboratory investigations revealed that GDF-15 has biphasic effects on cellular survival by several signaling pathways. GDF-15 participates in several cardiovascular pathological processes such as cardiac remodeling, ischemia/reperfusion injury and atherosclerotic plaque formation. As well, GDF-15 was found a prognostic biomarker of heart failure and acute coronary syndrome. The evidence for diagnostic or therapeutic utility is poor. CONCLUSION: GDF-15 has great potential as a biomarker in cardiovascular diseases, especially for prognosis, and is seen as a myocardial protective cytokine, but the exact mechanism of GDF-15 in cardiovascular diseases remains unknown.
CONTEXT: Growth differentiation factor 15 (GDF-15) is a novel cytokine showing close association with cardiovascular diseases. The biological mechanism and clinical use of GDF-15 in cardiovascular diseases have been well demonstrated. We review recent investigations from both basic research and clinical trials into the biological role of GDF-15. METHODS: The data were obtained mainly from MedLine via PubMed and from our own investigations. RESULTS: Laboratory investigations revealed that GDF-15 has biphasic effects on cellular survival by several signaling pathways. GDF-15 participates in several cardiovascular pathological processes such as cardiac remodeling, ischemia/reperfusion injury and atherosclerotic plaque formation. As well, GDF-15 was found a prognostic biomarker of heart failure and acute coronary syndrome. The evidence for diagnostic or therapeutic utility is poor. CONCLUSION:GDF-15 has great potential as a biomarker in cardiovascular diseases, especially for prognosis, and is seen as a myocardial protective cytokine, but the exact mechanism of GDF-15 in cardiovascular diseases remains unknown.
Authors: Saskia Koene; Paul de Laat; Doorlène H van Tienoven; Gert Weijers; Dennis Vriens; Fred C G J Sweep; Janneke Timmermans; Livia Kapusta; Mirian C H Janssen; Jan A M Smeitink Journal: JIMD Rep Date: 2015-05-13
Authors: Mary Putt; Virginia Shalkey Hahn; James L Januzzi; Heloisa Sawaya; Igal A Sebag; Juan Carlos Plana; Michael H Picard; Joseph R Carver; Elkan F Halpern; Irene Kuter; Jonathan Passeri; Victor Cohen; Jose Banchs; Randolph P Martin; Robert E Gerszten; Marielle Scherrer-Crosbie; Bonnie Ky Journal: Clin Chem Date: 2015-07-27 Impact factor: 8.327
Authors: Lars Wallentin; Björn Zethelius; Lars Berglund; Kai M Eggers; Lars Lind; Bertil Lindahl; Kai C Wollert; Agneta Siegbahn Journal: PLoS One Date: 2013-12-02 Impact factor: 3.240